Cochrane Abstracts
Recombinant human insulin‐like growth factor I (rhIGF‐I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Human Insulin‐like Growth Factor I (rhIGF‐I) for the Treatment of Amyotrophic Lateral Sclerosis/motor Neuron Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/Recombinant_human_insulin‐like_growth_factor_I__rhIGF‐I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease.
Recombinant human insulin‐like growth factor I (rhIGF‐I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/Recombinant_human_insulin‐like_growth_factor_I__rhIGF‐I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease. Accessed January 20, 2026.
Recombinant human insulin‐like growth factor I (rhIGF‐I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/Recombinant_human_insulin‐like_growth_factor_I__rhIGF‐I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease
Recombinant Human Insulin‐like Growth Factor I (rhIGF‐I) for the Treatment of Amyotrophic Lateral Sclerosis/motor Neuron Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/Recombinant_human_insulin‐like_growth_factor_I__rhIGF‐I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human insulin‐like growth factor I (rhIGF‐I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease
ID - 431249
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/Recombinant_human_insulin‐like_growth_factor_I__rhIGF‐I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
